Showing 861 - 880 results of 1,784 for search '(( 9 11 decrease ) OR ( 10 ((per decrease) OR (((nn decrease) OR (a decrease)))) ))*', query time: 0.17s Refine Results
  1. 861

    Salvia fruticosa Induces Vasorelaxation in Rat Isolated Thoracic Aorta: Role of the PI3K/Akt/eNOS/NO/cGMP Signaling Pathway by Anwar, M. Akhtar

    Published 2017
    “…Pretreatment of endothelium-intact rings with L-NAME (a non-selective inhibitor of nitric oxide synthase, 100 µM), or ODQ (an inhibitor of soluble guanylyl cyclase, 10 µM) significantly diminished SF-mediated vasorelaxation. …”
    Get full text
    Get full text
  2. 862
  3. 863
  4. 864
  5. 865
  6. 866
  7. 867
  8. 868

    Repositioning for pressure injury prevention in adults. by Gillespie, Brigid M

    Published 2020
    “…The intervention was reported to be cost-saving compared with standard care (nursing time cost per patient EUR 206.60 versus EUR 253.10, incremental difference EUR -46.50, 95% CI EUR -1.25 to EUR -74.60). …”
    Get full text
    Get full text
  9. 869
  10. 870
  11. 871

    Evaluation of different personalized ventilation air terminal devices: Inhalation vs. clothing-mediated exposures by Al Assaad, Douaa

    Published 2021
    “…The model was validated experimentally in a climatic chamber by comparing real-time particle mass concentration near a thermal manikin. …”
    Get full text
    Get full text
  12. 872
  13. 873
  14. 874
  15. 875
  16. 876

    Electrically conductive hybrid organic crystals as flexible optical waveguides by Li, Liang

    Published 2022
    “…In cyclic operation mode, their conductivity decreases less than 1% after 10,000 thermal cycles. …”
    Get full text
  17. 877
  18. 878
  19. 879

    Trends in prescribing and outcomes in obese versus non-obese patients receiving rivaroxaban therapy: an observational study using real-world data by Alalawneh, Majdoleen

    Published 2023
    “…Results The number of patients initiated on rivaroxaban therapy significantly increased from 152 (3.3%) in 2015 to 1342 (28.9%) in 2020 (p <0.001). Within BMI categories, a similar increasing trend was observed in underweight, normal, and overweight patients, while from 2018 to 2020, there was a decreasing trend in rivaroxaban prescribing in all obese classes. …”
    Get full text
    Get full text
  20. 880